Zawel Leigh 4/A
4/A · Cullinan Oncology, Inc. · Filed Aug 26, 2021
Insider Transaction Report
Form 4/AAmended
Zawel Leigh
See Remarks
Transactions
- Sale
Common Stock
2021-08-23$29.00/sh−28,118$815,422→ 93,524 total
Footnotes (2)
- [F1]Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on April 26, 2021.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.60 to $29.26. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.